<code id='BAED353380'></code><style id='BAED353380'></style>
    • <acronym id='BAED353380'></acronym>
      <center id='BAED353380'><center id='BAED353380'><tfoot id='BAED353380'></tfoot></center><abbr id='BAED353380'><dir id='BAED353380'><tfoot id='BAED353380'></tfoot><noframes id='BAED353380'>

    • <optgroup id='BAED353380'><strike id='BAED353380'><sup id='BAED353380'></sup></strike><code id='BAED353380'></code></optgroup>
        1. <b id='BAED353380'><label id='BAED353380'><select id='BAED353380'><dt id='BAED353380'><span id='BAED353380'></span></dt></select></label></b><u id='BAED353380'></u>
          <i id='BAED353380'><strike id='BAED353380'><tt id='BAED353380'><pre id='BAED353380'></pre></tt></strike></i>

          focus

          focus

          author:hotspot    Page View:1665

          Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. 

          How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

          advertisement

          STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

          Featured speakers:

          • LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
          • Ramita Tandon, chief clinical trials officer, Walgreens
          • Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
          • Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
          • Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

          Sponsored By

          OneStudyTeam

           

          knowledge

          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more
          Abbott's new heart device gets FDA advisory panel nod
          Abbott's new heart device gets FDA advisory panel nod

          ThedeviceiscalledtheTriClip,anditaddressesadiseasecalledtricuspidregurgitation:aheartconditionthatca

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          AMAs digital advisors table RPM coding reform proposal, again

          You’rereadingthewebeditionofSTAT’sHealthTechnewsletter,ourguidetohowtechnologyistransformingthelifes